DEA Emergency Scheduling of Mitragynine-Pseudoindoxyl Could Ban Kratom Containing Trace Amounts of the Molecule

Notice #DEA-1571 (Federal Register Docket #2026-13581) intends to ban mitragynine pseudoindoxyl with no legal threshold that allows for naturally occurring trace amounts in drying kratom leaves. AKA asks comedian Joe Rogan for help. Two Notices of Intent related to kratom alkaloids were filed by the Drug Enforcement Administration (DEA) on July 1, 2026. One, titled …

DEA Emergency Scheduling of Mitragynine-Pseudoindoxyl Could Ban Kratom Containing Trace Amounts of the Molecule Read More »

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition

Tonight at 11:59 PM, the Department of Health and Human Services (HHS) will close comments on the notice “Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information“. The notice asks for specific information and scientific evidence about the threshold of 7-OH that should be allowable in kratom products. However, many …

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition Read More »

Arizona Kratom Gummy Case Leaves Key Questions Unanswered

A recent case involving a 27-year-old Arizona woman who reportedly suffered heart failure after consuming kratom gummies has drawn national attention. The woman reportedly took the gummies for leg pain and only took them for one week. While the incident has been widely reported, many of the most important details remain unknown. One of the …

Arizona Kratom Gummy Case Leaves Key Questions Unanswered Read More »

Fallout of the Kansas and Tennessee Kratom Bans

When prohibition is enacted, the consequences rarely unfold in the neat, orderly way lawmakers imagine. Just two weeks underway, the July 1 kratom bans in Kansas and Tennessee offer a real‑time case study in how criminalization can destabilize entire communities overnight. In Kansas, the decision to classify kratom and 7‑hydroxymitragynine (7-OH) as Schedule I substances …

Fallout of the Kansas and Tennessee Kratom Bans Read More »

DEA Announces Temporary 7-OH Ban; Public Comment Period Underway

On July 6, the United States Drug Enforcement Agency (DEA) published a notice in the Federal Register that it intends to place 7-hydroxymitragynine (7-OH) on Schedule I of the Controlled Substances Act. This is an emergency rule that would temporarily place covered 7-OH products in Schedule I for up to two years while the DEA …

DEA Announces Temporary 7-OH Ban; Public Comment Period Underway Read More »

Scientists Find Kratom Alkaloids in Products Marketed as Kava in Alabama

In a study published June 30 in Clinical Toxicology, scientists found mitragynine, 7-hydroxymitragynine, and mitragynine-pseudoindoxyl in three liquid shot products being sold as “kava” in Alabama. Alabama law specifically lists mitragynine and 7-hydroxymitragynine as Schedule I controlled substances. Though mitragynine-pseudoindoxyl is not specifically listed as a controlled substance in the state, it is controlled as …

Scientists Find Kratom Alkaloids in Products Marketed as Kava in Alabama Read More »

Kratom Will Be Banned In Kansas and Tennessee Starting July 1

Beginning July 1, laws designating kratom as a Schedule I controlled substance will take effect in both Kansas and Tennessee. In March, Kansas legislators added a last-minute kratom ban into a bill having nothing to do with kratom (HB2365 originally entitled “Establishing the south central regional mental health hospital”). The bill passed both the Kansas …

Kratom Will Be Banned In Kansas and Tennessee Starting July 1 Read More »

NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status

On June 1, the National Institutes of Health (NIH) announced that mitragynine, the most abundant alkaloid in kratom, has been cleared as an Investigational New Drug (IND). With IND status, scientists at University of Florida are now authorized to study the effects of pure mitragynine in human subjects. National Institute on Drug Abuse (NIDA) Director …

NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status Read More »

Proposed Philadelphia Kratom Regulations Would be a Defacto Ban on Sales

Formally introduced on March 5, 2026 by Katherine Gilmore Richardson, proposed Philadelphia City Council legislation would impose strict licensing, testing, packaging, and approval requirements on kratom products sold in the city. Supporters of the bill argue the rules are necessary to address concerns about synthetic extracts, youth access, mislabeled products, and the growing number of …

Proposed Philadelphia Kratom Regulations Would be a Defacto Ban on Sales Read More »

Brian Setzer’s Kratom Tonic Problem and the Fallout of Aggressive Marketing to Uninformed Consumers

Musician Brian Setzer of The Stray Cats and Brian Setzer Orchestra told Guitar Player that his comeback to the music business was hampered by a kratom dependency. “It started innocently enough,” says Setzer… “They advertise it as a safe tonic to give you energy, and it’s not. So that just aggravated the whole thing. I …

Brian Setzer’s Kratom Tonic Problem and the Fallout of Aggressive Marketing to Uninformed Consumers Read More »